
(Circulation. 2000;102:3086.)
© 2000 American Heart Association, Inc.
Abnormal Baroreflex Responses in Patients With
Idiopathic Orthostatic Intolerance
William B. Farquhar, PhD;
J. Andrew Taylor, PhD; Stephen E. Darling, BS;
Karen P. Chase, RN; Roy Freeman, MD
From the Center for Autonomic and Peripheral Nerve
Disorders (W.B.F., S.E.D., K.P.C., R.F.), Department of Neurology, Beth
Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass,
and HRCA Research and Training Institute and Harvard Medical School
Division on Aging (W.B.F., J.A.T.), Boston, Mass.
Correspondence to Roy Freeman, MD, Beth Israel
Deaconess Medical Center, Boston, MA 02215. E-mail
rfreeman@caregroup.harvard.edu
Background—Patients
diagnosed with idiopathic orthostatic intolerance report
symptoms of lightheadedness, fatigue, and nausea accompanied
by an exaggerated tachycardia when assuming the upright
posture. Often, these symptoms are present in the absence of
any decrease in arterial pressure. We hypothesized that
patients with idiopathic orthostatic intolerance would have
impaired cardiac vagal and integrated baroreflex function, lower
blood volume, and increased venous compliance.
Methods and Results—Sixteen
patients and 14 healthy control subjects underwent the
modified Oxford technique to assess cardiac vagal baroreflex
sensitivity. Progressive lower-body negative pressure (to –50
mm Hg; LBNP) was used to examine the integrated baroreflex
response to progressive hypovolemic stimuli. Blood volume and
venous compliance were also assessed. Patients with idiopathic
orthostatic intolerance had lower cardiac vagal baroreflex
sensitivity (12±1 versus 25±4 ms/mm Hg; P 0.01).
The integrated baroreflex response to low levels of LBNP was
characterized by shorter R-R intervals and more symptoms such
as lightheadedness, despite similar levels of blood pressure.
There was a trend toward lower blood volume in the patient
group (56±2 versus 63±3 mL/kg; P=0.054).
Conclusions—Patients with
idiopathic orthostatic intolerance have lower cardiac vagal
baroreflex sensitivity and marginally lower blood volume and
respond with faster heart rates despite similar levels of
arterial pressure during LBNP. These findings may contribute
to the exaggerated postural tachycardia and symptoms observed
in patients with this disorder.
Key Words: baroreceptors • blood pressure • tachycardia
• nervous system, autonomic
Estimates indicate that up to 500 000 Americans suffer
from some form of orthostatic intolerance. A disproportionate
number of women are affected.1
Diagnostic terms used to describe this idiopathic syndrome
include postural orthostatic tachycardia syndrome,
hyperadrenergic orthostatic tachycardia, idiopathic
hypovolemia, partial dysautonomia, and chronic orthostatic intolerance.2
3 4
5 6
7 8 The
pathophysiological basis of this disorder is unknown.
However, all forms of idiopathic orthostatic intolerance
encompass some combination of symptoms of lightheadedness, fatigue,
nausea, palpitations, and cognitive impairment. Moreover,
hemodynamically, an exaggerated tachycardia is apparent when
upright posture is assumed, yet this feature typically occurs
without any decrease in arterial pressure.
Despite the apparent maintenance of arterial pressure,
deficits in cardiovascular regulation may play a primary role
in this disorder. Cardiovascular adjustments to acute
increases and decreases in arterial pressure require
effective reflex responses to ensure appropriate autonomic
outflow. Abnormalities in reflex autonomic control, blood
volume, and blood volume distribution, alone or in combination,
may result in orthostatic intolerance. However, to date, arterial
and cardiopulmonary reflex gains and their relation to blood
volume and its distribution have not been characterized in
patients with idiopathic orthostatic intolerance.9
We hypothesized that impaired baroreflex function
might be responsible for the features of this disorder.
Baroreflex impairment has been associated with a
hyperadrenergic state,10
11 thereby providing a possible explanation
for the exaggerated tachycardia observed in this patient
population. Furthermore, the inappropriate increase in heart
rate and increased sympathetic outflow may cause some of the
symptoms reported by this patient group.9
Reports of impaired vagal baroreflex function with an exaggerated
tachycardia and orthostatic intolerance in young healthy men
after head-down bed rest lend support to this hypothesis.12
We therefore assessed the cardiovagal baroreflex with the modified
Oxford technique and the integrated baroreflex with lower-body
negative pressure (LBNP) using low- and high-level hypovolemic
stimuli.
Furthermore, because chronic hypovolemia and/or
increased venous pooling may be contributing factors to
symptoms of orthostatic intolerance, we also measured blood
volume and lower-limb venous compliance. We hypothesized that
patients with idiopathic orthostatic intolerance would have
lower blood volume and increased venous compliance.
Subjects
Sixteen patients and 14 healthy control subjects agreed to participate
in this institutionally approved study. Patients recruited for
the study had idiopathic orthostatic intolerance defined by
symptoms of orthostatic intolerance and an increase in heart
rate of >30 bpm within 10 minutes of standing without orthostatic
hypotension.
Patients and control subjects were required to be free
from any acute illness or chronic disease. All participants
completed questionnaires, including the autonomic symptom
questionnaire, orthostatic tolerance questionnaire, and
fatigue severity scale.13
Protocol Overview
In the week preceding the protocol, subjects discontinued all
medications for at least 5 half-lives and were instructed to
follow a diet containing 100
mEq of sodium, 75 mEq of potassium, 2500 mL of fluid, and
1800 kcal per day. Subjects
were also asked to refrain from caffeine and alcohol
consumption. Compliance to the assigned diet was assessed by
use of a 5-day diet record. We controlled activity level,
food intake, and fluid intake during the 2-day protocol by
having subjects report to the clinical research center for
the study duration.
Day 1
Plasma and Blood Volume Determination
Plasma volume was determined by a single bolus injection (3.0
to 3.5 mL) of Evans blue dye (New World Trading). Absorbance
of the plasma samples was read with a spectrophotometer (Beckman
Spectrophotometer, Beckman Instruments Inc) at 620 nm 10, 20, and
30 minutes after the injection. Hematocrit (Hct) was determined
with a microcentrifuge and corrected for peripheral sampling
(0.91) and trapped plasma (0.96). Blood volume (BV) was
calculated with the formula BV=PV/(1–Hctcorr),
where PV indicates plasma volume.14
Venous Compliance
Compliance of the left calf was assessed by a technique as outlined
by Convertino et al.15 After 30
minutes of supine rest, a mercury-in-silastic strain gauge (D.E.
Hokanson) was placed around the calf and an occlusion cuff
around the thigh. The thigh cuff was inflated twice at 30 and
50 mm Hg for a period of 4 minutes. Percent volume change at
the plateau point during the thigh cuff inflation was divided
by the cuff pressure and used as an index of lower-leg venous
compliance.
Standard Autonomic Testing
Baseline cardiac vagal function was determined by the difference
between maximum and minimum heart rate during paced breathing.
Supine subjects were trained to breathe deeply for 90 seconds
at a rate of 6 breaths per minute. A Valsalva maneuver was
performed in triplicate by having subjects expire for 15
seconds against a resistance of 40 mm Hg.16
These (and subsequent) data were recorded and digitized with
WinDaq Data Acquisition Software (DATAQ Instruments).
Day 2
Cardiac Vagal Baroreflex Sensitivity
The modified Oxford technique17 was used
to assess cardiac vagal baroreflex sensitivity. A bolus
injection of the vasodilator sodium nitroprusside (100 µg)
was followed 60 seconds later by a bolus injection of the
vasoconstrictor phenylephrine hydrochloride (150 µg) to
induce a fall and subsequent rise in arterial blood pressure
of 15 to 20 mm Hg below and
above baseline. This sequence was repeated 3 times with 15
minutes of quiet rest between trials. The relation of R-R
interval (ECG) to beat-by-beat systolic pressure (Finapres)
during the pressure rise (from nadir to peak; an ascending
pressure stimulus) provides a measure of baroreflex control
of cardiac vagal outflow. R-R interval was regressed against
3 mm Hg systolic pressure ranges. Because the relationship between
systolic pressure and R-R interval is sigmoidal18
and not linear, a 4-parameter sigmoid was fit to the data
(TableCurve, Jandel Scientific) to calculate peak gain and
the R-R interval operating range.18
Gain was also calculated by the standard approach, in which
a straight line was regressed for the data points falling in
the linear section of the curve between the threshold and
saturation region.
Integrated Baroreflex Assessment
Graded LBNP was used to induce a gradual decline in central
blood volume without the confounding effects of muscle contraction.
Supine subjects were placed in a metal tank. A neoprene skirt
was used to obtain an airtight seal at the waist. After a 5-minute
baseline data collection period, negative pressures of –10, –20,
–30, –40, and –50 mm Hg were generated. Although
low-level LBNP (to –20 mm Hg) is commonly used to isolate the
cardiopulmonary baroreceptors, recent data indicate arterial
baroreceptor involvement.19
20 Each stage lasted 5 minutes. Respiration (Respitrace),
R-R interval (ECG), beat-by-beat blood pressure (Finapres),
oscillometric blood pressure (Dinamap, Critikon Co), and
forearm vascular resistance (FVR; mean arterial pressure
divided by forearm blood flow, in arbitrary units) were
recorded. Forearm blood flow was determined with a mercury-in-silastic
strain gauge placed around the forearm. A rapid cuff inflator
(D.E. Hokanson) was used to inflate and deflate the cuff. The
volume of blood pooling in the lower extremity was estimated
throughout the protocol by a previously placed strain gauge.
Statistics
Data are expressed as mean±SEM. Unpaired t tests were
used to compare responses between healthy controls and patients
diagnosed with idiopathic orthostatic intolerance. A P
level <0.05 was considered significant. A 2-way ANOVA (group,
patients versus controls; time, levels of negative pressure)
with repeated measures was used to evaluate low-level LBNP
(–10 and –20 mm Hg stages) and all levels of LBNP (SAS
statistical software, SAS Institute Inc). Preplanned
comparisons were performed with unpaired t tests
whenever the ANOVA detected a significant effect. Because the
present investigation focused on autonomic cardiovascular
control, data on cardiac chronotropy were analyzed and are
reported by R-R interval. However, where appropriate, data
were also analyzed by heart rate.
Subject Characteristics
Subject demographics can be found in Table 1 .
Data obtained from the questionnaires indicated that all
patients diagnosed with idiopathic orthostatic intolerance
reported symptoms of lightheadedness or dizziness with
standing. All patients also reported fatigue as a major
symptom. Other frequently reported symptoms included a rapid
heart rate/palpitations (88%) and nausea (57%). Eighty-one
percent (13/16) of the patients met the revised Centers for
Disease Control and Prevention (CDC) criteria for a diagnosis
of chronic fatigue syndrome (CFS).21 None
of the healthy control subjects reported a regular occurrence
of symptoms such as lightheadedness or fatigue.
Plasma/Blood Volume and Venous Compliance
Baseline plasma volume (38.0±1.4 versus 42.5±2.1 mL/kg, P=0.09)
and blood volume (55.8±1.8 versus 63.2±3.1 mL/kg, P=0.054)
tended to be lower in patients than controls. Hematocrit was
similar (37.3±0.6 versus 38.0±1.1%, P=0.53), and
venous compliance was lower in patients than in controls
(2.5±0.2 versus 3.7±0.4 AU, P<0.05).
Baseline Hemodynamic Assessment
Baseline resting heart rate (76±3 versus 67±2 bpm, P 0.02)
and mean arterial pressure (93±3 versus 82±2 mm Hg, P=0.009)
were higher in patients. There were no differences in the
maximum-minimum heart rate difference with deep respiration
or the Valsalva ratio (see Table 1 ).
There was a difference in the minimum heart rate achieved
during the blood pressure rise of the Valsalva maneuver
(phase IV), with patients having an attenuated slowing of
heart rate compared with controls (see Table 1 ).
There was also a trend (P=0.19) for patients to have a faster
heart rate in response to the pressure fall during the Valsalva
maneuver (see Table 1 ).
Cardiac Vagal Baroreflex Sensitivity
An example of the sigmoidal relationship between systolic pressure
and R-R interval for a representative patient and control subject
can be found in Figure 1 .
Cardiac vagal baroreflex gain with the modified Oxford
technique was significantly lower (P 0.01)
in patients than in control subjects (see Figure 2 ).
Patients also had a significantly lower gain when a straight
line was regressed in the linear region of the systolic
pressure–R-R interval relationship (data not shown). Similar
differences were also noted in the heart rate–derived
baroreflex gains (–1.6±0.3 versus –2.4±0.3 bpm/mm Hg, P 0.05).
There was a trend for the R-R interval operating range to be
lower in patients (323±31 ms) than in controls (456±66 ms,
P=0.09).

View larger version (16K):
[in this window]
[in a new window]
|
Figure
1. Example of sigmoid
relationship between systolic blood pressure and R-R
interval in representative patient and control subject.
Note lower slope (cardiac vagal baroreflex gain) and R-R
interval operating range in patient. OI indicates
orthostatic intolerance.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
Figure
2. Mean±SEM responses for
cardiac vagal baroreflex gain in patients and control
subjects. Differences were highly significant (P 0.01).
|
|
Integrated Baroreflex Assessment
LBNP data can be found in Table 2 .
Across all levels of negative pressure, there was a
progressive shortening of R-R interval, a decline in arterial
pressure, an increase in FVR, and an increase in calf
circumference for patients and controls (ANOVA, P 0.05).
There was no change in respiration rate in patients and controls
during the protocol. For low-level LBNP, the ANOVA detected
a significant group (patients versus controls) effect for R-R
interval, with patients having a significantly shorter R-R
interval at the –10 and –20 mm Hg stage (Figure 3 ).
The slope of the response between negative pressure applied
and R-R interval was also steeper (more negative) in patients
than in controls for the –10 and –20 mm Hg stage (–5.0 versus
–2.2 ms/mm Hg). Because only 5 total subjects (4 patients
and 1 control) were able to complete the –50 mm Hg stage
(the others reported presyncopal symptoms along with a decline
in blood pressure), the –50 mm Hg stage was not used in
the statistical analysis. We also related the changes in R-R
interval, heart rate, and FVR to changes in calf circumference
and found no differences in slope (data not shown). However,
marked intersubject and intrasubject variability in calf
circumference precluded us from drawing a definitive
conclusion based on these assessments. Although data are
presented as R-R intervals, analyses were also performed with
heart rate. Similar differences were found.

View larger version (13K):
[in this window]
[in a new window]
|
Figure
3. Mean±SEM R-R interval
responses to low levels of LBNP in patients and control
subjects. ANOVA detected a significant group effect (P 0.05,
patients vs controls) for R-R interval, and post hoc
analysis revealed differences to be at the –10 and –20
mm Hg stages.
|
|
Idiopathic orthostatic intolerance has become an increasingly
recognized disorder, with patients typically complaining of
lightheadedness, nausea, and fatigue when assuming the upright posture.
These symptoms are associated with an exaggerated postural-induced
tachycardia. The primary aim of the current study was to examine
possible physiological correlates of idiopathic orthostatic
intolerance. The major finding is that patients who present
with symptoms of orthostatic intolerance have depressed
cardiac vagal baroreflex sensitivity. This difference in
dynamic heart rate control does not appear to be related to
deficits in vagal efferent activity, because
respiratory-mediated vagal modulation of heart rate variability,
as assessed by the maximum minus minimum heart rate difference,
was not different in patients versus controls.
The present data differ from an earlier report in
which it was concluded that baroreflex sensitivity is
preserved in patients with chronic orthostatic intolerance.7
Importantly, however, those data revealed strong trends
toward impaired cardiac vagal baroreflex sensitivity in the
patient group, derived from both
-index (P<0.06
between groups) and steady-state vasoactive drug infusions (P<0.08
between groups). The impaired baroreflex gains are also
consistent with a more recent report by the same group.8
The link between impaired cardiac vagal baroreflex sensitivity
and orthostatic intolerance has been demonstrated previously
in young healthy men after head-down bed rest, where low
baroreflex sensitivity and a restricted R-R interval
operating range (ie, buffer capacity) were associated with
orthostatic hypotension.12
These data, however, are only partially applicable to the present
study in that patients with idiopathic orthostatic intolerance
are defined by a lack of significant orthostatic hypotension.
We also examined cardiovascular control during
baroreflex disengagement utilizing lower-body suction as a
descending pressure stimulus. At low levels of LBNP, we
observed the R-R interval was significantly shorter in
patients than in controls. For example, at the –20 mm Hg
stage, patients had a 21% shorter R-R interval. Prior studies
have used low levels of LBNP to isolate the cardiopulmonary reflex;
however, more recent data suggest that there is also engagement of
the arterial baroreflex, precluding the interpretation that
this is a specific alteration in the cardiopulmonary reflex.19
20
Taken together, these data indicate that the altered
control of heart rate reported in this patient group may be
due to arterial baroreflex dysfunction; that is, these
patients are not able to properly slow heart rate in response
to baroreflex engagement during an ascending pressure
stimulus, which leads to an exaggerated tachycardia.
Furthermore, impaired baroreflex function may be responsible
for the increased central sympathetic outflow that has been
reported in patients with chronic orthostatic intolerance and
may be responsible in part for the postural tachycardia. It
is of interest that the increased sympathetic outflow observed
in both animal models and human studies of congestive heart
failure is associated with and may be secondary to impaired
baroreflex control.10
11 22
In summary, whether an ascending or descending
pressure stimulus is used, patients with idiopathic
orthostatic intolerance respond with faster heart rates than
healthy control subjects, which suggests differential gains.
This is also supported by the minimum (P=0.05 between
groups) and maximum (P=0.19 between groups) heart rates
achieved during the pressure rise and fall of the Valsalva
maneuver.
The pathophysiological basis of symptoms of
orthostatic intolerance in the absence of hypotension is
unknown. In the present study, despite a similar
physiological stress (a gradual decline in externally applied
negative pressure, arterial pressure, and blood pooling), a
qualitative assessment of symptoms during the LBNP protocol indicated
that patients experienced more symptoms such as lightheadedness
or dizziness than the healthy control subjects. This may suggest
a more heightened sensitivity to a rapid heart rate in patients
with idiopathic orthostatic intolerance. Although there are
no reports that have assessed symptoms during rapid cardiac
pacing in supine patients with orthostatic intolerance,9
the present data suggest that this patient group may respond
adversely to an inappropriate tachycardia. The present data
also appear to support the speculation that symptoms of
orthostatic intolerance are elicited by central responses to
the inappropriate tachycardia,9 and
dysfunction within the baroreflex arc as a possible cause of
the tachycardia.
Hypovolemia and increased venous compliance may
contribute to orthostatic intolerance. Our data indicate that
this group of patients had a 13% lower blood volume (P=0.054)
than their age-matched healthy counterparts. Jacob et al23
reported lower blood volume and a reduced plasma renin
activity in a group of patients with orthostatic intolerance.
Lower blood volume may cause a compensatory increase in
sympathetic outflow, contributing to the suspected
hyperadrenergic state previously reported in similar patients.7
Although the present data only indicate strong trends for
differences in plasma and blood volume, hypovolemia may
nonetheless play an important role in the pathogenesis of
this disorder.
A previous study5 has
drawn attention to the presence of increased venous
denervation and pooling in patients with hyperadrenergic
orthostatic hypotension. We hypothesized that patients with
idiopathic orthostatic intolerance (without hypotension) would
also have alterations in venous compliance. Against expectations,
the present data indicate that patients had lower venous
compliance than controls, indicating that this does not
appear to play a contributing pathophysiological role. Two
possibilities may explain this finding. First, increased
sympathetic outflow to the venous system may result in a
decrease in venous compliance.24
Alternatively, it is possible that incomplete venous
drainage, due to excessive venous pooling before the
compliance measurement was begun, left the patients at a
higher starting point on the venous compliance curve.
Although we used standard techniques for measuring venous compliance,15
this approach may not be suitable for patients with orthostatic
intolerance. This issue merits further study.
A functional dysautonomia of the limbs causing
vasoconstrictor failure has been suggested as a possible
cause of orthostatic intolerance.5
6 Limb vasoconstriction during
orthostatic stress has been used as an index of sympathetic
function. In the present study, both patients and control
subjects responded with an appropriate increase in FVR,
providing no evidence of autonomic dysfunction of the upper
limbs. We did not assess sympathetic vasoconstrictor function
of the lower limbs during the LBNP protocol.
Symptoms of orthostatic intolerance are manifest in a
broad spectrum of disorders. For example, this disorder is
associated with the CFS, with some suggesting that
orthostatic intolerance may contribute to the fatigue
associated with CFS.25
26 27 The patients
recruited for the current study had a diagnosis of idiopathic
orthostatic intolerance, with most (13/16) also meeting the
CDC criteria for a diagnosis of CFS.21
The high percentage (81%) of patients in the current study
that meet the CDC definition for CFS makes these data unique.
Chronic fatigue is a common complaint in patients with
idiopathic orthostatic intolerance, and there appears to be
considerable overlap between the 2 disorders. The current
patient cohort also meets the commonly used diagnostic
criteria for postural tachycardia syndrome.
There are several possible study limitations. Central
venous pressure was not measured; instead, changes in calf
circumference were used as a noninvasive index of blood
pooling during LBNP. The amount of blood pooled during the
protocol was not significantly different between groups.
LBNP may not duplicate the stress of standing. This
appears to be particularly true in the present study, because
more patients than controls were able to complete the –50 mm
Hg stage. However, as discussed, the patients responded at
lower levels of LBNP with faster heart rates and more
symptoms.
In summary, the present data indicate that arterial
baroreflex function is altered in patients with idiopathic
orthostatic intolerance, possibly contributing to the
exaggerated tachycardia and symptoms of orthostatic
intolerance.
This study was supported in part by grant 1 R01 HL 59459
from the National Heart, Lung, and Blood Institute and RR
01032 from the National Center for Research Resources,
National Institutes of Health. Further support was provided
in part by grant AG08812 to Harvard Medical School Division
on Aging, grant AG05134 to the Hebrew Rehabilitation Center
for Aged, and grant M01-RR01032 to Beth Israel Deaconess
Medical General Clinical Research Center.
Received June 20, 2000; revision received August 3,
2000; accepted August 3, 2000.
- Robertson D. The epidemic of orthostatic tachycardia
and orthostatic intolerance. Am J Med Sci. 1999;317:75–77.[Medline]
- Frohlich ED, Tarazi RC, Dustan HP. Hyperdynamic
beta-adrenergic circulatory state: increased beta-receptor
responsiveness. Arch Intern Med. 1969;123:1–7.[Medline]
- Rosen SG, Cryer PE. Postural tachycardia syndrome:
reversal of sympathetic hyperresponsiveness and clinical improvement
during sodium loading. Am J Med. 1982;72:847–850.[Medline]
- Fouad FM, Tadena-Thome L, Bravo EL, et al. Idiopathic
hypovolemia. Ann Intern Med. 1986;104:298–303.[Medline]
- Streeten DH. Pathogenesis of hyperadrenergic
orthostatic hypotension: evidence of disordered venous innervation
exclusively in the lower limbs. J Clin Invest.
1990;86:1582–1588.[Medline]
- Schondorf R, Low PA. Idiopathic postural orthostatic
tachycardia syndrome: an attenuated form of acute pandysautonomia?
Neurology. 1993;43:132–137.[Abstract]
- Furlan R, Jacob G, Snell M, et al. Chronic orthostatic
intolerance: a disorder with discordant cardiac and vascular
sympathetic control. Circulation. 1998;98:2154–2159.[Abstract/Free
Full Text]
- Jacob G, Shannon JR, Costa F, et al. Abnormal
norepinephrine clearance and adrenergic receptor sensitivity in
idiopathic orthostatic intolerance. Circulation.
1999;99:1706–1712.[Abstract/Free
Full Text]
- Narkiewicz K, Somers VK. Chronic orthostatic
intolerance: part of a spectrum of dysfunction in orthostatic
cardiovascular homeostasis? Circulation. 1998;98:2105–2107.
Editorial.[Free
Full Text]
- Ferguson DW, Berg WJ, Roach PJ, et al. Effects of
heart failure on baroreflex control of sympathetic neural activity
[see comments]. Am J Cardiol. 1992;69:523–531.[Medline]
- Chen JS, Wang W, Bartholet T, et al. Analysis of
baroreflex control of heart rate in conscious dogs with
pacing-induced heart failure. Circulation. 1991;83:260–267.[Abstract]
- Convertino VA, Doerr DF, Eckberg DL, et al. Head-down
bed rest impairs vagal baroreflex responses and provokes orthostatic
hypotension. J Appl Physiol. 1990;68:1458–1464.[Abstract/Free
Full Text]
- Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue
severity scale: application to patients with multiple sclerosis and
systemic lupus erythematosus. Arch Neurol. 1989;46:1121–1123.[Abstract]
- Greenleaf JE, Convertino VA, Mangseth GR. Plasma
volume during stress in man: osmolality and red cell volume. J
Appl Physiol. 1979;47:1031–1038.[Abstract/Free
Full Text]
- Convertino VA, Doerr DF, Stein SL. Changes in size
and compliance of the calf after 30 days of simulated microgravity.
J Appl Physiol. 1989;66:1509–1512.[Abstract/Free
Full Text]
- Low PA. Laboratory evaluation of autonomic function.
In: Low PA, ed. Clinical Autonomic Disorders: Evaluation and
Management. Philadelphia, Pa: Lippincott-Raven Publishers;
1997:179–208.
- Ebert TJ, Cowley AW Jr. Baroreflex modulation of
sympathetic outflow during physiological increases of vasopressin in
humans. Am J Physiol. 1992;262(pt 2):H1372–H1378.
- Sprenkle JM, Eckberg DL, Goble RL, et al. Device for
rapid quantification of human carotid baroreceptor-cardiac reflex
responses. J Appl Physiol. 1986;60:727–732.[Abstract/Free
Full Text]
- Lacolley PJ, Pannier BM, Slama MA, et al. Carotid
arterial haemodynamics after mild degrees of lower-body negative
pressure in man. Clin Sci (Colch). 1992;83:535–540.[Medline]
- Taylor JA, Halliwill JR, Brown TE, et al. "Non-hypotensive"
hypovolaemia reduces ascending aortic dimensions in humans. J
Physiol (Lond). 1995;483(pt 1):289–298.
- Fukuda K, Straus SE, Hickie I, et al. The chronic
fatigue syndrome: a comprehensive approach to its definition and
study: International Chronic Fatigue Syndrome Study Group. Ann
Intern Med. 1994;121:953–959.[Abstract/Free
Full Text]
- Eckberg DL, Drabinsky M, Braunwauld E, et al.
Defective cardiac parasympathetic control in patients with heart
disease. N Engl J Med. 1971;285:877–883.[Medline]
- Jacob G, Shannon JR, Black B, et al. Effects of
volume loading and pressor agents in idiopathic orthostatic
tachycardia. Circulation. 1997;96:575–580.[Abstract/Free
Full Text]
- Zelis R, Mason DT. Comparison of the reflex
reactivity of skin and muscle veins in the human forearm. J Clin
Invest. 1969;48:1870–1877.[Medline]
- Streeten DH, Anderson GH Jr. Delayed orthostatic
intolerance [see comments]. Arch Intern Med.
1992;152:1066–1072.[Abstract]
- Rowe PC, Bou-Holaigah I, Kan JS, et al. Is neurally
mediated hypotension an unrecognized cause of chronic fatigue?
Lancet. 1995;345:623–624.[Medline]
- Freeman R, Komaroff AL. Does the chronic fatigue
syndrome involve the autonomic nervous system? Am J Med.
1997;102:357–364.[Medline]

Top
|